by Joel Rothman | Sep 18, 2006 | NutriSupLaw
The infomercial is a popular marketing vehicle for nutraceuticals and alternative medical devices. Recently, unscrupulous infomercial marketers have come under attack for unfair and deceptive trade practices. These two examples provide important lessons for makers of...
by Joel Rothman | Sep 7, 2006 | NutriSupLaw
FDA issued this press release yesterday regarding a seizure at Florida supplement company Advantage Nutraceuticals, LLC. The press release doesn’t say which part of FDA this comes from but one would assume it originates in the Center for Food Safety and Applied...
by Joel Rothman | Aug 29, 2006 | NutriSupLaw
In a 23 page opinion, a panel of the United States Court of Appeals for the Tenth Circuit has reversed the Utah District Court and held that the FDA’s ban on low dose ephedra was not arbitrary or capricious. Next stop, Supreme Court? Neutraceutical Corp. v. Von...
by Joel Rothman | Jul 13, 2006 | NutriSupLaw
The Fourth Circuit Court of Appeals has ruled that Durk Pearson and Sandy Shaw jumped the gun when they sued the FDA for declaratory and injunctive relief to prevent the agency from stopping them from publishing a US government study on the effectiveness of SAMe...
by Joel Rothman | Jul 10, 2006 | NutriSupLaw
The FDA has scheduled a public hearing on the regulation of foods being marketed as “functional foods.” According to this Federal Register Notice, the purpose of the hearing is “for the agency to share its current regulatory framework and rationale...
